Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin

J. Posthuma de Boer; P.W. van Egmond; M.N. Helder; R. Xavier de Menezes; A.M. Cleton-Jansen; J.A.M. Belien; H.M.W. Verheul; B.J. van Royen; G.J.L. Kaspers; V.W. van Beusechem

doi:10.18632/oncotarget.600

Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin

J. Posthuma de Boer
, P.W. van Egmond
, M.N. Helder
, R. Xavier de Menezes
, A.M. Cleton-Jansen
, J.A.M. Belien
, H.M.W. Verheul
, B.J. van Royen
, G.J.L. Kaspers
, V.W. van Beusechem

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1169-1181
Journal	Oncotarget
Volume	3
Issue number	10
DOIs	https://doi.org/10.18632/oncotarget.600
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.18632/oncotarget.600

http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=600

Cite this

@article{129f3bbcfd5d495f818d424456475be4,

title = "Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin",

author = "\{Posthuma de Boer\}, J. and \{van Egmond\}, P.W. and M.N. Helder and \{Xavier de Menezes\}, R. and A.M. Cleton-Jansen and J.A.M. Belien and H.M.W. Verheul and \{van Royen\}, B.J. and G.J.L. Kaspers and \{van Beusechem\}, V.W.",

year = "2012",

doi = "10.18632/oncotarget.600",

language = "Undefined/Unknown",

volume = "3",

pages = "1169--1181",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "10",

}

TY - JOUR

T1 - Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin

AU - Posthuma de Boer, J.

AU - van Egmond, P.W.

AU - Helder, M.N.

AU - Xavier de Menezes, R.

AU - Cleton-Jansen, A.M.

AU - Belien, J.A.M.

AU - Verheul, H.M.W.

AU - van Royen, B.J.

AU - Kaspers, G.J.L.

AU - van Beusechem, V.W.

PY - 2012

Y1 - 2012

U2 - 10.18632/oncotarget.600

DO - 10.18632/oncotarget.600

M3 - Article

C2 - 23045411

SN - 1949-2553

VL - 3

SP - 1169

EP - 1181

JO - Oncotarget

JF - Oncotarget

IS - 10

ER -